PCSA
PCSA
NASDAQ · Pharmaceuticals

Processa Pharmaceuticals Inc

$2.02
-0.06 (-2.88%)
As of Jun 23, 10:18 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,726.7% upside
Low Target $23.79
Average Target $36.90
High Target $41.20
Current Price $2.02
Current
$2.02
Target
$36.90
$23.79 $36.90 avg $41.20
Scenario Analysis
Bear Case
$23.79
1,077.7%
Low target
Base Case
$36.90
+1,726.7%
Avg target
Bull Case
$41.20
+1,939.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.24
-85.8% from high
52-Week Low
$1.76
+14.8% from low
Target vs 52W High
$36.90
+159.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%